7Baggers
 Fennec Pharmaceuticals Hits Day High with Strong 7.98% Intraday Surge  Markets Mojo Wed, 01 Oct 2025 21:36:24 GMT
 (FRX) Strategic Equity Report (FRX:CA)  news.stocktradersdaily.com Sun, 28 Sep 2025 22:15:14 GMT
 Fennec's Pedmarqsi gets nod from U.K. regulators  MSN Sun, 28 Sep 2025 13:26:42 GMT
 (frx) comprehensive trading strategy report (frx:ca)  news.stocktradersdaily.com Fri, 26 Sep 2025 01:29:14 GMT
 public market insider buying at fennec pharmaceuticals (frx)  The Globe and Mail Wed, 17 Sep 2025 10:15:13 GMT
 published on: 2025-09-12 05:33:49  Newser Fri, 12 Sep 2025 10:33:49 GMT
 published on: 2025-09-12 04:58:44  Newser Fri, 12 Sep 2025 09:58:44 GMT
 published on: 2025-09-11 19:04:48  Newser Fri, 12 Sep 2025 00:04:48 GMT
 published on: 2025-09-11 17:27:06  Newser Thu, 11 Sep 2025 22:27:06 GMT
 published on: 2025-09-11 05:27:51  Newser Thu, 11 Sep 2025 10:27:51 GMT
 published on: 2025-09-09 02:18:21  Newser Tue, 09 Sep 2025 07:18:21 GMT
 published on: 2025-09-08 04:52:05  Newser Mon, 08 Sep 2025 09:52:05 GMT
 published on: 2025-09-08 03:18:01  Newser Mon, 08 Sep 2025 08:18:01 GMT
 Fennec Pharmaceuticals Rings the Closing Bell  Nasdaq Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 04:52:27  Newser Wed, 03 Sep 2025 09:52:27 GMT

Fennec Pharmaceuticals Inc
(NASDAQ:FENC) 

FENC stock logo

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced heari...

Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends